The global anaesthesia machine market is valued at US$ 15.70 Billion in 2026 and is projected to reach US$ 27.43 Billion by 2033, growing at a CAGR of 8.3%.
Market growth is driven by increasing healthcare infrastructure investments and the rising adoption of robotic-assisted surgical procedures worldwide.
Continuous Anaesthesia Machines lead with a 61.8% market share due to their widespread use as the standard platform for prolonged and complex surgical procedures.
North America dominates with a 38.7% market share, supported by high surgical volumes, advanced healthcare infrastructure, and favorable reimbursement systems.
The largest opportunity lies in the expanding ambulatory surgical center and office-based anaesthesia segment, which is driving demand for compact and cost-efficient systems.